Culture & Sensitivity – Bone Marrow at Dr. Essa Lab

Culture & Sensitivity – Bone Marrow at Dr. Essa Lab

The Culture & Sensitivity – Bone Marrow test at Dr. Essa Lab is a highly specialized, gold-standard microbiological investigation designed to isolate, identify, and analyze pathogenic microorganisms residing within the bone marrow cavity. The bone marrow, a highly vascularized tissue located within the medullary cavities of bones, serves as the primary site for hematopoiesis and is an integral component of the reticuloendothelial system. Because of its unique anatomical and physiological characteristics, the bone marrow acts as a sanctuary and reservoir for various intracellular pathogens, fastidious bacteria, fungi, and parasites that may evade detection in standard peripheral blood cultures. This diagnostic evaluation is critical for patients presenting with complex, systemic infectious processes, particularly when conventional diagnostic modalities have yielded inconclusive results.

During this advanced laboratory investigation, a small volume of bone marrow aspirate is obtained via a sterile clinical procedure and immediately inoculated into specialized, highly enriched culture media. These media are designed to support the growth of a wide array of organisms, including aerobic and anaerobic bacteria, mycobacteria, and fungi. Once growth is detected, clinical microbiologists at Dr. Essa Lab perform identification procedures followed by antimicrobial susceptibility testing (AST). This secondary phase determines which specific therapeutic agents are most effective at eradicating the isolated pathogen, thereby guiding targeted, evidence-based antimicrobial therapy. The diagnostic value of a bone marrow culture is unparalleled in cases of prolonged pyrexia of unknown origin (PUO), suspected enteric fever with prior antibiotic exposure, disseminated tuberculosis, systemic fungal infections, and visceral leishmaniasis.

Clinical Procedure: What to Expect

Patient Preparation

Undergoing a bone marrow aspiration requires careful and systematic preparation to ensure patient safety, minimize discomfort, and maintain the sterile integrity of the specimen. Patients scheduled for this procedure at Dr. Essa Lab must adhere to the following clinical guidelines:

• Coagulation Profile Assessment: Patients must undergo a baseline coagulation screen, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and International Normalized Ratio (INR), along with a complete platelet count, to evaluate the risk of post-procedural bleeding.
• Medication Review: It is essential to inform the prescribing physician and the laboratory staff of all current medications. Antiplatelet agents (such as aspirin or clopidogrel) and anticoagulants (such as warfarin or novel oral anticoagulants) may need to be temporarily discontinued under strict medical supervision.
• Informed Consent: The clinical team will explain the indications, risks, benefits, and steps of the procedure, after which the patient or a legal guardian must sign an informed consent form.
• Dietary Guidelines: While absolute fasting is generally not required for a local anesthetic procedure, patients are advised to consume a light meal a few hours prior to the appointment to prevent vasovagal episodes or dizziness.
• Allergy Notification: Patients must disclose any known allergies, particularly to local anesthetics (like lidocaine), antiseptic solutions (such as chlorhexidine or povidone-iodine), or latex.

During the Procedure

The bone marrow aspiration is performed under strict aseptic conditions by a qualified hematologist, clinical pathologist, or trained medical specialist. The step-by-step clinical process involves:

• Patient Positioning: The patient is typically placed in a prone (face down) or lateral decubitus (side-lying) position to allow optimal access to the posterior superior iliac spine (PSIS) of the pelvis, which is the safest and most common site for aspiration.
• Sterile Site Preparation: The skin overlying the selected site is thoroughly cleansed with a surgical-grade antiseptic solution and draped with sterile towels to establish a sterile field.
• Local Anesthesia: The clinician infiltrates the skin, subcutaneous tissues, and, crucially, the highly sensitive periosteum of the bone with a local anesthetic (usually 1% or 2% lidocaine) to minimize pain.
• Aspiration Process: A specialized, sterile bone marrow aspiration needle (such as a Jamshidi or Illinois needle) is introduced through the anesthetized tract. With controlled pressure and a rotating motion, the needle penetrates the outer cortical bone to enter the spongy medullary cavity.
• Specimen Collection: A sterile syringe is attached to the needle hub, and approximately 1 to 3 milliliters of bone marrow aspirate is drawn. The patient may experience a brief, sharp, pulling or suction sensation during this phase.
• Post-Procedure Care: The needle is carefully withdrawn, and firm, direct pressure is applied to the puncture site with sterile gauze for several minutes to achieve hemostasis. A sterile pressure dressing is then applied, and the patient is monitored for a brief period before discharge.

When is a Culture & Sensitivity – Bone Marrow Performed?

Pyrexia of Unknown Origin (PUO)

Pyrexia of Unknown Origin is clinically defined as a persistent fever exceeding 38.3°C (101°F) on multiple occasions, lasting for more than three weeks, with no diagnosis reached despite one week of intensive inpatient or outpatient investigation. In these challenging clinical scenarios, the bone marrow culture serves as an invaluable diagnostic tool. Because the bone marrow contains a high concentration of macrophages and reticuloendothelial cells, it sequesters slow-growing, fastidious, and intracellular pathogens that are often cleared from or present in extremely low quantities in peripheral blood. Isolating these organisms from the marrow aspirate provides a definitive diagnosis, allowing clinicians to initiate targeted therapy and avoid empirical treatment failures.

Suspected Enteric Fever (Typhoid)

Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi, remains a significant public health concern in developing regions. While peripheral blood cultures are highly useful during the first week of illness, their diagnostic sensitivity drops precipitously thereafter, particularly if the patient has already self-administered or been prescribed oral antibiotics. Bone marrow culture is widely recognized as the gold standard for diagnosing enteric fever because Salmonella bacilli persist within the intracellular compartment of the bone marrow long after they have cleared from the bloodstream. The sensitivity of bone marrow culture remains exceptionally high (up to 90%) even after several days of antibiotic therapy, making it a critical diagnostic resource for refractory cases.

Disseminated Mycobacterial Infections

In immunocompromised individuals, such as patients with advanced HIV/AIDS, those undergoing active chemotherapy, or transplant recipients on immunosuppressive regimens, atypical and typical mycobacterial infections can present as disseminated diseases. Mycobacterium tuberculosis and non-tuberculous mycobacteria (such as the Mycobacterium avium complex) have a strong tropism for the reticuloendothelial system. Bone marrow aspiration and subsequent culture provide a highly sensitive method for isolating these acid-fast bacilli. Detecting these slow-growing organisms allows for precise speciation and drug susceptibility testing, which is vital given the rise of multidrug-resistant tuberculosis (MDR-TB) strains.

Visceral Leishmaniasis (Kala-Azar)

Visceral Leishmaniasis is a severe, potentially fatal systemic parasitic disease caused by protozoan parasites of the genus Leishmania, transmitted through the bite of infected sandflies. The parasite targets the reticuloendothelial system, multiplying within macrophages in the liver, spleen, and bone marrow. Patients present with prolonged fever, massive splenomegaly, hepatomegaly, severe anemia, and pancytopenia. Culturing the bone marrow aspirate on specialized media (such as Novy-MacNeal-Nicolle medium) allows for the isolation and microscopic visualization of the flagellated promastigote stage of the parasite, confirming the diagnosis when serological tests are equivocal.

Disseminated Fungal Infections and Brucellosis

Systemic mycoses, including histoplasmosis, cryptococcosis, and coccidioidomycosis, as well as chronic bacterial infections like brucellosis, frequently manifest with vague, constitutional symptoms and bone marrow involvement. Brucella species are fastidious, intracellular bacteria that reside within the phagocytic cells of the bone marrow. Standard blood cultures often fail to detect these organisms due to their slow growth rates and low concentration in peripheral blood. Bone marrow culture provides an enriched environment that significantly enhances the recovery rate of these pathogens, enabling accurate identification and susceptibility profiling to prevent chronic, debilitating complications.

What Does a Culture & Sensitivity – Bone Marrow Detect?

The Culture & Sensitivity – Bone Marrow test is capable of detecting a wide spectrum of pathogenic microorganisms, including:

• Salmonella enterica serovar Typhi: The causative agent of classical typhoid fever.
• Salmonella enterica serovar Paratyphi (A, B, and C): Pathogens responsible for paratyphoid fever.
• Brucella melitensis & Brucella abortus: Zoonotic bacteria causing chronic, undulating brucellosis.
• Mycobacterium tuberculosis: The primary pathogen responsible for tuberculosis, presenting here as disseminated or miliary disease.
• Mycobacterium avium-intracellulare Complex (MAC): Opportunistic mycobacteria frequently infecting immunocompromised hosts.
• Leishmania donovani: The protozoan parasite responsible for visceral leishmaniasis (Kala-azar).
• Histoplasma capsulatum: A dimorphic fungus causing systemic histoplasmosis, particularly in the reticuloendothelial system.
• Cryptococcus neoformans: An encapsulated yeast capable of causing disseminated infections and meningitis.
• Staphylococcus aureus (including MRSA): Pyogenic bacteria that can cause osteomyelitis or hematogenous seeding of the marrow.
• Streptococcus pneumoniae: A major bacterial pathogen capable of causing severe systemic infections.
• Escherichia coli: Gram-negative bacilli associated with opportunistic, nosocomial, or systemic infections.
• Klebsiella pneumoniae: An opportunistic pathogen frequently associated with multi-drug resistance.
• Pseudomonas aeruginosa: A highly resilient, opportunistic bacterium causing severe systemic infections in hospitalized patients.
• Acinetobacter baumannii: A multi-drug resistant nosocomial pathogen.
• Candida albicans & Candida non-albicans species: Yeasts capable of causing deep-seated, disseminated candidiasis.
• Aspergillus fumigatus: An opportunistic mold that can disseminate to the bone marrow in severely neutropenic patients.
• Coccidioides immitis: The causative agent of coccidioidomycosis, presenting as disseminated disease.
• Blastomyces dermatitidis: A dimorphic fungus causing systemic blastomycosis.
• Penicillium marneffei (Talaromyces marneffei): An opportunistic fungus endemic in certain regions, affecting immunocompromised individuals.
• Listeria monocytogenes: A Gram-positive rod capable of causing systemic infection in newborns, the elderly, and the immunocompromised.
• Neisseria meningitidis: A pathogen that can rarely be isolated from bone marrow during meningococcemia.
• Nocardia species: Opportunistic, branching bacteria that can cause disseminated nocardiosis.
• Absence of Aerobic Pathogens: Indicating no growth of common aerobic bacteria.
• Absence of Anaerobic Pathogens: Indicating no growth of obligate anaerobic bacteria.
• Absence of Acid-Fast Bacilli (AFB): Confirming no mycobacterial growth.
• Absence of Fungal Elements: Confirming no fungal growth.
• Antimicrobial Susceptibility Profiles: Detailed reports indicating whether the isolated pathogen is Susceptible (S), Intermediate (I), or Resistant (R) to specific therapeutic agents.

Turnaround Time and Report Access at Dr. Essa Lab

The turnaround time (TAT) for a Culture & Sensitivity – Bone Marrow test at Dr. Essa Lab varies significantly depending on the specific type of pathogen suspected and the growth characteristics of the organism. Standard aerobic and anaerobic bacterial cultures are monitored continuously in automated systems; preliminary reports are typically available within 48 to 72 hours, while final negative reports are issued after 5 to 7 days of incubation. However, fastidious organisms like Brucella species require extended incubation of up to 14 to 21 days. Mycobacterial cultures (AFB) and fungal cultures require specialized media and prolonged incubation periods, often taking 3 to 6 weeks to confirm a true negative result. Dr. Essa Lab utilizes advanced automated culture monitoring systems to detect growth at the earliest possible juncture, minimizing delays in clinical decision-making.

Patients and referring physicians can access diagnostic reports through Dr. Essa Lab’s secure online portal and dedicated mobile application. Once the clinical pathologists and microbiologists verify the findings, an automated SMS notification is sent to the patient with a direct link to download the electronic report. Physical copies of the reports can also be collected from any of the numerous Dr. Essa Lab diagnostic centers located across Karachi and other major cities. This seamless digital integration ensures that critical diagnostic data is delivered promptly to the healthcare team, facilitating timely therapeutic interventions.

Culture & Sensitivity – Bone Marrow Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Aerobic Bacterial Culture	No growth of aerobic pathogenic bacteria after standard incubation.	Isolation of pathogens such as Salmonella typhi, Staphylococcus aureus, or Gram-negative bacilli.
Anaerobic Bacterial Culture	No growth of obligate anaerobic bacteria.	Isolation of anaerobic pathogens (e.g., Bacteroides, Clostridium species).
Mycobacterial Culture (AFB)	No growth of acid-fast bacilli after extended incubation (up to 6-8 weeks).	Growth of Mycobacterium tuberculosis or atypical mycobacteria (MAC).
Fungal Culture	No fungal growth observed after 21 to 28 days of incubation.	Isolation of opportunistic or systemic fungi (e.g., Histoplasma, Cryptococcus, Candida).
Parasitic Evaluation (Smear/Culture)	No parasitic organisms detected.	Presence of Leishmania donovani amastigotes (Leishman-Donovan bodies) or promastigotes.
Gram Stain of Aspirate	No microorganisms or inflammatory cells observed.	Presence of Gram-positive/negative bacteria or yeast cells, often accompanied by abundant neutrophils.
Acid-Fast Stain (ZN Stain)	No acid-fast bacilli (AFB) detected.	Visualization of red, rod-shaped acid-fast bacilli, highly suggestive of mycobacterial infection.
Antimicrobial Susceptibility Profile	Not applicable (no pathogen isolated).	Identification of specific resistance patterns (e.g., ESBL, MRSA, MDR, or XDR strains).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Culture & Sensitivity – Bone Marrow?

• Experienced Healthcare Professionals: Dr. Essa Lab features a team of highly qualified consultant pathologists, clinical microbiologists, and laboratory technologists specializing in complex hematopathological and microbiological analyses.
• Patient-Focused Care: The laboratory prioritizes patient comfort, safety, and clear communication throughout the diagnostic process, ensuring a supportive environment during invasive procedures.
• Quality Diagnostic Services: Operating with strict adherence to international quality control standards, Dr. Essa Lab delivers highly accurate and reproducible diagnostic results.
• Professional Reporting: Reports are meticulously reviewed and signed by certified consultants, providing detailed, actionable clinical insights and antimicrobial susceptibility profiles.
• Modern Diagnostic Approach: Utilizing state-of-the-art automated culture systems and advanced identification technologies to detect fastidious and slow-growing pathogens rapidly.
• Comfortable Environment: Procedures are conducted in dedicated, sterile, and comfortable clinical rooms designed to minimize patient anxiety and ensure absolute hygiene.
• Convenient Location: With an extensive network of diagnostic centers across Karachi and other regions, patients can easily access services and collect reports.
• Commitment to Accurate Diagnosis: Dr. Essa Lab maintains a legacy of diagnostic excellence established in 1987, serving as a trusted partner for healthcare providers nationwide.